Gut bacteria may influence immunotherapy success in mesothelioma patients

A cancer study has found that certain gut bacteria may influence whether or not a patient’s immune system is successful in fighting mesothelioma, an aggressive form of cancer.

Novo Holdings acquires Catalent for $16.5bn – Pharmaceutical Technology

Share this article Novo Holdings, the Novo Nordisk Foundation’s holding and investment company, announced plans for a $16.5bn acquisition of Catalent. Credit: NurPhoto / Getty

February 5, 2024

Alzheimer’s Onset Delayed by Rare Mutation

One copy of the APOE3 Christchurch variant delayed onset of autosomal dominant Alzheimer’s disease. Mild cognitive impairment occurred 5 years later than expected in people

June 20, 2024

ViiV Healthcare to increase annual supply of long-acting HIV PrEP

The long-acting injectable PrEP option is being rolled out at a record pace in sub-Saharan Africa and lower-income countries. Credit: elenavolf/Shutterstock. ViiV Healthcare has announced

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.